azathioprine has been researched along with Hepatitis D in 3 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To establish the impact of cyclosporine on the development of chronic hepatitis in hepatitis B surface antigen (HBsAg)-positive renal allograft recipients, the incidence and outcome of chronic hepatitis in 20 cyclosporine-treated patients (CsA group) were compared with 13 azathioprine-treated patients (AZA group)." | 3.68 | Hepatitis B liver disease in cyclosporine-treated renal allograft recipients. ( Fong, MT; Huang, CC; Lai, MK, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lengyel, G | 1 |
| Hopf, U | 1 |
| Neuhaus, P | 1 |
| Lobeck, H | 1 |
| König, V | 1 |
| Küther, S | 1 |
| Bauditz, J | 1 |
| Bechstein, WO | 1 |
| Blumhardt, G | 1 |
| Steffen, R | 1 |
| Neuhaus, R | 1 |
| Huang, CC | 1 |
| Lai, MK | 1 |
| Fong, MT | 1 |
3 other studies available for azathioprine and Hepatitis D
| Article | Year |
|---|---|
[Therapeutic principles after liver transplantation].
Topics: Azathioprine; Cyclosporine; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Immunosuppressive | 1996 |
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Hepatitis B; Hepatitis B virus; | 1991 |
Hepatitis B liver disease in cyclosporine-treated renal allograft recipients.
Topics: Adolescent; Adult; Azathioprine; Cyclosporins; Female; Hepatitis Antibodies; Hepatitis B; Hepatitis | 1990 |